Diabetes Digital Health and Telehealth

1st Edition - August 3, 2022
Editors: David C. Klonoff, David Kerr, Elissa R. Weitzman
Language: English
Paperback ISBN:
9 7 8 - 0 - 3 2 3 - 9 0 5 5 7 - 2
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 9 0 6 7 6 - 0

Diabetes Digital Health and Telehealth explains, from technologic, economic and sociologic standpoints how digital health and telehealth have come to dominate the management of dia… Read more

Purchase options

ROBOTICS & AUTOMATION

Empowering Progress

Up to 25% off Essentials Robotics and Automation titles

Explore now

Image with Robotics & Automation book covers

Institutional subscription on ScienceDirect

Request a sales quote

Diabetes Digital Health and Telehealth explains, from technologic, economic and sociologic standpoints how digital health and telehealth have come to dominate the management of diabetes. The book also includes information on improved telemedicine tools and platforms for communicating with patients, reviewing medical records, and interpreting data from wearable devices. In addition, evolving wearable sensors such as continuous glucose monitors, closed loop automated insulin delivery systems, cuffless blood pressure monitors, exercise monitors and smart insulin pens are covered.

Cover image
Title page
Table of Contents
Copyright
Contributors
Preface
Acknowledgments
Part I. Building digital health and telehealth tools for diabetes
Chapter 1. Democratizing access to and understanding of health information in the era of telehealth
Summary
Statistics
Introduction
What is the current status of health information access in the era of telehealth?
What are barriers to progress to health information access in the era of telehealth?
What is needed to advance health information access in the era of telehealth?
What is the future of health information access in the era of telehealth?
Conclusion
Chapter 2. Building digital health tools for diabetes: how user experience research and user interface design can improve digital health adoption
Summary
Statistics
Introduction
What is the current status of UI/UX?
What are the barriers to progress of UI/UX design?
What technologies, processes, or training are needed to advance the experience for all patients with diabetes?
What is the future of digital health and diabetes?
Conclusion
Chapter 3. Integrating diabetes technology data in the EHR
Summary
Statistics
Introduction
The current status of incorporating diabetes technology data into the EHR
What are barriers to progress in incorporating diabetes technology data into the EHR?
What is needed to advance the field?
What is the future of diabetes technology data in the EHR?
Conclusion
Chapter 4. Interoperability risks and health informatics
Summary
Statistics
Introduction
What is the current status of medical device interoperability?
What are barriers to progress of medical device interoperability?
What technologies, processes, training, or policies are needed to advance the field of medical device interoperability?
What is the future of medical device interoperability?
Conclusion
Chapter 5. Cybersecurity in the diabetes care ecosystem
Summary
Statistics
Introduction
Current status of cybersecurity in diabetes care
Barriers to progress to cybersecurity in diabetes care
Technologies, processes, training, or policies needed to advance the field
What is the future of cybersecurity in diabetes care?
Conclusion
Chapter 6. Privacy and diabetes digital technologies and telehealth services
Summary
Statistics
Introduction
Current status
Barriers to advancing privacy
What's needed to advance the field?
Conclusion and recommendations
Chapter 7. Telehealth and digital health privacy regulations
Summary
Statistics
Introduction
What is the current status of federal and state privacy law?
What are barriers to progress to federal and state privacy law?
What technologies, processes, training, or policies are needed to advance federal and state privacy law?
What is the future of federal and state privacy law?
Chapter 8. Business considerations in starting a diabetes digital health start-up
Summary
Statistics
Introduction
Conclusion
Part II. Diabetes digital health and telehealth for individuals
Chapter 9. Digital health apps for people with diabetes
Summary
Statistics
Introduction
What is the current status and evidence on digital health apps for diabetes?
What are barriers to progress in mobile health app development?
What processes and policies are needed to advance the development of mobile apps?
What is the future of mobile health apps?
Conclusion
Chapter 10. Telehealth for diabetes: a durable, evolving solution
Summary
Statistics
Introduction
Current status of telehealth for diabetes
Barriers to telehealth progress
What is needed to advance the field?
What is the future of telehealth for diabetes?
Conclusion
Chapter 11. Digital health and telehealth for behavior change in diabetes
Summary
Statistics
Introduction
What is the current status of digital health and telehealth for behavior change in diabetes?
What are the barriers to progress to digital health and telehealth for behavior change in diabetes?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of digital health and telehealth for behavior change in diabetes?
Conclusion
Chapter 12. Digital support for physical activity
Summary
Statistics
Introduction
What is the current status of digital support for PA?
What are barriers to progress to digital support for PA?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of digital support for PA?
Conclusion
Chapter 13. Psychosocial responses to telehealth for diabetes care
Summary
Statistics
Introduction
Current status of psychosocial responses to telehealth for diabetes care
What are barriers to progress in psychosocial responses to diabetes telehealth?
What technologies, processes, training, or policies are needed to advance the field of psychosocial care in diabetes telehealth?
What is the future of psychosocial aspects of diabetes telehealth?
Conclusion
Chapter 14. Remote blood pressure monitoring
Summary
Statistics
Introduction
The current status of remote blood pressure monitoring
What are barriers to progress?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of remote blood pressure monitoring?
Conclusion
Chapter 15. Digital health and telehealth for pregnancy
Summary
Statistics
Introduction
What is the current status of digital health and telehealth for pregnancy?
Pregestational diabetes
Mobile apps
What are barriers to progress to digital health and telehealth for pregnancy?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of digital health and telehealth for pregnancy?
Conclusion
Chapter 16. Digital health technologies for patients in diabetes self-management education and support
Summary
Statistics
Introduction
Digital technology for DSMES: current status
Digital technology facilitated person-centered DSMES
Identifying the problem
Shared decision-making
Barriers to progress role of digital technology in DSMES
Future of digital health in DSMES
Conclusion
Part III. Diabetes digital health and telehealth for populations
Chapter 17. Use of digital health and telehealth in the US
Summary
Statistics
Introduction
What is the current status of digital health and telehealth?
What are barriers to progress for digital health and telehealth?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of digital health and telehealth?
Conclusion
Chapter 18. Diabetes digital health and telehealth in the Middle East
Summary
Statistics
Introduction
What is the current status of diabetes digital health and telehealth in the Middle East?
What are the barriers to broader adoption of diabetes digital health and telehealth in the Middle East?
What is needed to advance the utilization of diabetes digital health and telehealth in the Middle East?
What is the future of diabetes digital health and telehealth in the Middle East?
Conclusion
Chapter 19. An Asian perspective on digital health for diabetes
Summary
Statistics
Introduction
What is the current status of digital health for diabetes in Asia?
What are barriers to progress in digital health in Asia?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of digital health in Asia?
Chapter 20. Impact of digital technology on managing diabetes in the hospital
Summary
Statistics
Introduction
Status of digital health tools for managing diabetes in the hospital
Barriers to the progress of digital technologies
Technologies, processes, training, or policies needed to advance digital technologies
The future of digital health tools in the hospital
Conclusion
Chapter 21. Disparities in digital health in underserved populations
Summary
Statistics
Introduction
What is the current status of disparities in digital health/telehealth in underserved populations?
What are barriers to progress addressing disparities in underserved populations?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of disparities in digital health access and use among underserved populations?
Conclusion
Chapter 22. Telehealth for training diabetes professionals
Summary
Statistics
Introduction
What is the current status of telehealth for training diabetes professionals?
What are the barriers to progress to telehealth for training diabetes professionals?
What technologies, processes, training, or policies are needed to advance the field?
What is the future of telehealth for training diabetes professionals?
Conclusion
Chapter 23. Outcomes assessment for digital health interventions in diabetes: a payer perspective
Summary
Statistics
Introduction
What is the current status of digital health interventions for diabetes?
Digital health interventions for diabetes: barriers to progress
Processes and policies needed to advance the field
The future of digital health interventions for diabetes
Conclusion
Index

David C. Klonoff

Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF.

Affiliations and expertise

Clinical Professor of Medicine, U.C. San Francisco,Mills-Peninsula Medical Center, San Mateo, California, USA.

David Kerr

David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with David’s appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.

David’s recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health.

David’s research has also included the use of “food-as-medicine” for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained “Community Scientists” from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes.

You can follow David on ‘X’ at @godiabetesmd.

Affiliations and expertise

Sutter Health Center for Health Systems Research, Santa Barbara, California, USA Rice University, Houston, Texas, USA

Elissa R. Weitzman

Dr. Elissa R. Weitzman is Associate Professor of Pediatrics at Harvard Medical School, and of Adolescent/Young Adult Medicine at Boston Children's Hospital. Her research focuses on improving the health of youth, with an emphasis on addressing chronic illness and behavioral health problems. A mixed-methods scientist, Weitzman uses narrative, cohort, and “big data” passive or participatory surveillance methods to illuminate the epidemiology and experience of chronic illness. Recognizing population engagement with digital health tools and online disease communities, she has investigated willingness to share electronic data for research, quantified the quality and safety of online health communities, and tested informatics-enabled models for returning research data to cohorts to drive engagement. Weitzman has a Bachelor’s from Brandeis University, a Masters and Doctorate from the Harvard TH Chan School of Public Health, and has completed post-doctoral training in Medical Ethics and Public Health in Psychiatry at the Harvard Medical School.

Affiliations and expertise

Associate Professor of Pediatrics, Harvard Medical School,Boston, Massachusetts, USA; Associate Professor of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, Massachusetts, USA

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Diabetes Digital Health and Telehealth

Purchase options

Empowering Progress

Institutional subscription on ScienceDirect

David C. Klonoff

David Kerr

Elissa R. Weitzman